US Patent 8003606 Inhibiting serum response factor (SRF) to improve insulin sensitivity

Patent 8003606 was granted and assigned to Joslin Diabetes Center (company) on August, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Joslin Diabetes Center (company)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8003606

Date of Patent

August 23, 2011

Patent Application Number

12479390

Date Filed

June 5, 2009

Patent Primary Examiner

‌

Amy Bowman

Patent abstract

Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity, and methods of identifying new compounds for use in the described methods of treatment.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8003606 Inhibiting serum response factor (SRF) to improve insulin sensitivity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API